L3VLUP
ProSign in

TWST · GILD in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

TWSTGILD
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • TWST
  • GILD
010203040202120222023202420252026
Holders and value by quarter
QuarterTWSTGILD
Q3 20209 holders, $726m25 holders, $14.2bn
Q4 202010 holders, $1.9bn27 holders, $13.4bn
Q1 202110 holders, $1.7bn24 holders, $14.5bn
Q2 20219 holders, $1.8bn18 holders, $14.9bn
Q3 20217 holders, $1.1bn20 holders, $16.4bn
Q4 20213 holders, $739m20 holders, $16.8bn
Q1 20225 holders, $601m28 holders, $13.2bn
Q2 20224 holders, $324m26 holders, $13.6bn
Q3 20225 holders, $343m24 holders, $13.3bn
Q4 20226 holders, $247m32 holders, $21.1bn
Q1 20235 holders, $142m27 holders, $21.8bn
Q2 20235 holders, $220m24 holders, $20.7bn
Q3 20236 holders, $294m24 holders, $20.0bn
Q4 20235 holders, $476m22 holders, $21.5bn
Q1 20245 holders, $468m30 holders, $20.3bn
Q2 20249 holders, $758m28 holders, $18.5bn
Q3 20246 holders, $594m29 holders, $24.2bn
Q4 20246 holders, $620m28 holders, $25.9bn
Q1 20257 holders, $579m33 holders, $32.0bn
Q2 20256 holders, $547m27 holders, $30.9bn
Q3 20254 holders, $405m23 holders, $29.4bn
Q4 20254 holders, $465m25 holders, $34.3bn
Q1 20268 holders, $794m25 holders, $38.5bn
Q2 202610 holders, $1.8bn26 holders, $34.2bn
TWST

Twist Bioscience Corp

Holders
9
Reported value
$758m
Buyers
6
Sellers
4

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
GILD

Gilead Sciences Inc

Holders
28
Reported value
$18.5bn
Buyers
15
Sellers
14

Breadth +1 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q2 2024

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only TWST (5)

ARK Investment Management LLC, Artisan Partners LP, Baillie Gifford & Co, Caxton Associates LLP, Farallon Capital Management LLC

Only GILD (24)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Millennium Management LLC, Renaissance Technologies LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →